Healio Rheumatology Current Issue
The following articles appeared in the print edition of Healio Rheumatology.
Table of Contents
- Prioritization and Management of Comorbidities in Rheumatoid Arthritis
-
- Osteoporosis and Inflammatory Bowel Disease
- Top Checkpoint Inhibitor Stories From ACR 2016
- CHMP Recommends Approval for Baricitinib for Moderate to Severe Active RA
- No Treatment-Emergent Issues Found After Switching From Infliximab to SB2
- Comorbidities in Rheumatoid Arthritis: More Work or Part of Job? Leonard H. Calabrese, DO
- The Patient With Fibromyalgia
- More Questions Than Answers Remain on Trump Administration's Focus on Health Care
- EULAR Updates Recommendations for Early Arthritis
-
- FDA Bans Powdered Surgeon's Gloves
- ACP: Repeal, Replacement of ACA Would Negatively Impact Health Care Industry
- First-Line Etanercept With MTX Increased Cost-Effectiveness Ratio by $88,815 per QALY
- Gastric Bypass Associated With Reduced Risk for Psoriasis, Psoriatic Arthritis
- Gum Bacterium Linked to Rheumatoid Arthritis
- Population-Based Study: Low Annual Incidence of Mixed Connective Tissue Disease
- Study: Methotrexate Underused as Treatment for Patients With RA
- Triple Therapy Seen as More Cost-Effective Than Etanercept Therapies
-
- Brentuximab Vedotin Improves CTCL Outcomes Over Methotrexate, Bexarotene
- VIDEO: 'Intriguing' Data in Lymphoma Emerge From ASH
- ACR Supports CMS Removal of Part B Proposal
- CMS Expands Opportunities Under the Quality Payment Program
- Study: Joint, Muscle Pain Common With the Use of Immune Checkpoint Inhibitors
- Talks Focus on the Nuances of Fibromyalgia Management
- VIDEO: How to Switch to More Aggressive RA Treatment